FDA Okays Naldemedine (Symproic) for Opioid Constipation FDA Okays Naldemedine (Symproic) for Opioid Constipation

The FDA has approved an oral peripherally acting mu opioid receptor antagonist for treatment of opioid-induced constipation.FDA Approvals
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Neurology & Neurosurgery News Alert Source Type: news